Literature DB >> 7166178

Human metabolism of tolfenamic acid. I. Isolation, preliminary characterization and pharmacokinetics of tolfenamic acid and its metabolites.

P J Pentikäinen, A Penttilä, P J Neuvonen, R G Khalifah, C E Hignite.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7166178     DOI： 10.1007/BF03189628

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN： 0378-7966            Impact factor:   2.441


× No keyword cloud information.
  2 in total

1.  Age differences in drug binding by plasma proteins: studies on human foetuses, neonates and adults.

Authors:  M Ehrnebo; S Agurell; B Jalling; L O Boréus
Journal:  Eur J Clin Pharmacol       Date:  1971-09       Impact factor: 2.953

2.  Human pharmacokinetics of tolfenamic acid, a new anti-inflammatory agent.

Authors:  P J Pentikäinen; P J Neuvonen; C Backman
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953
  2 in total
  5 in total

1.  Pharmacokinetics of tolfenamic acid in pediatric patients after single oral dose.

Authors:  I Niopas; M Georgarakis; V Sidi-Frangandrea; C Chrisanthopoulos; E Liara
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1995 Oct-Dec       Impact factor: 2.441

2.  Pharmacokinetics of tolfenamic acid in patients with cirrhosis of the liver.

Authors:  J Stenderup; J Eriksen; S B Pedersen; L V Christiansen
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

3.  Pharmacokinetics of tolfenamic acid: disposition in bile, blood and urine after intravenous administration to man.

Authors:  P J Pentikäinen; O Tokola; E Alhava; A Penttilä
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  Protein binding of tolfenamic acid in the plasma from patients with renal and hepatic disease.

Authors:  M Láznícek; K E Senius
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

5.  Biocompatible Cationic Lipoamino Acids as Counterions for Oral Administration of API-Ionic Liquids.

Authors:  Anthony Lai; Nathania Leong; Dan Zheng; Leigh Ford; Tri-Hung Nguyen; Hywel D Williams; Hassan Benameur; Peter J Scammells; Christopher J H Porter
Journal:  Pharm Res       Date:  2022-06-03       Impact factor: 4.580
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.